Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring Healthy Retinal Aging with Deep Learning.
Menten MJ, Holland R, Leingang O, Bogunović H, Hagag AM, Kaye R, Riedl S, Traber GL, Hassan ON, Pawlowski N, Glocker B, Fritsche LG, Scholl HPN, Sivaprasad S, Schmidt-Erfurth U, Rueckert D, Lotery AJ. Menten MJ, et al. Among authors: kaye r. Ophthalmol Sci. 2023 Mar 1;3(3):100294. doi: 10.1016/j.xops.2023.100294. eCollection 2023 Sep. Ophthalmol Sci. 2023. PMID: 37113474 Free PMC article.
Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2.
Hagag AM, Kaye R, Hoang V, Riedl S, Anders P, Stuart B, Traber G, Appenzeller-Herzog C, Schmidt-Erfurth U, Bogunovic H, Scholl HP, Prevost T, Fritsche L, Rueckert D, Sivaprasad S, Lotery AJ. Hagag AM, et al. Among authors: kaye r. Surv Ophthalmol. 2024 Mar-Apr;69(2):165-172. doi: 10.1016/j.survophthal.2023.10.010. Epub 2023 Oct 27. Surv Ophthalmol. 2024. PMID: 37890677 Free article. Review.
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
Lotery A, Sivaprasad S, O'Connell A, Harris RA, Culliford L, Ellis L, Cree A, Madhusudhan S, Behar-Cohen F, Chakravarthy U, Peto T, Rogers CA, Reeves BC; VICI trial investigators. Lotery A, et al. Lancet. 2020 Jan 25;395(10220):294-303. doi: 10.1016/S0140-6736(19)32981-2. Lancet. 2020. PMID: 31982075 Clinical Trial.
Recurrent bacterial keratitis.
Kaye R, Kaye A, Sueke H, Neal T, Winstanley C, Horsburgh M, Kaye S. Kaye R, et al. Among authors: kaye s, kaye a. Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4136-9. doi: 10.1167/iovs.13-12130. Invest Ophthalmol Vis Sci. 2013. PMID: 23696605
The TMEM16A channel as a potential therapeutic target in vascular disease.
Al-Hosni R, Kaye R, Choi CS, Tammaro P. Al-Hosni R, et al. Among authors: kaye r. Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):161-169. doi: 10.1097/MNH.0000000000000967. Epub 2024 Jan 8. Curr Opin Nephrol Hypertens. 2024. PMID: 38193301 Free PMC article. Review.
324 results